Public
American Hospital Association content that is available to the public and all website users.
The AHA asks that as the House begins drafting the FY 2027 appropriations bill, it funds health care programs that have proven successful in improving access to quality health care for patients and communities across America.
The American Hospital Association (AHA) and the West Health Institute announced a new three-year initiative to help hospitals and health systems operationalize and scale proven technologies across care environments to improve patient outcomes and support care teams.
The AHA’s new award, the Carolyn Boone Lewis Award for Improving Health Outcomes, will recognize excellence in applying data-informed strategies to effectively improve health outcomes for all.
Hospitals are balancing significant cost pressures as they treat a sicker and more medically complex, aging patient population, all while operating with persistent misalignments in how care is financed and reimbursed.
The Rural Hospital Leadership Team Award from the AHA Rural Health Services honors the leadership team who has guided their hospital and community through transformational change on the road to health care reform innovation.
CMS introduced the first wave of interoperable digital solutions to improve patient experiences and enhance care delivery as part of the agency’s HealthTech Ecosystem initiative.
Don’t miss the chance to share actionable strategies and connect with your peers at the premier gathering of rural health leaders.
Renowned speakers from across health care will provide in-depth guidance and actionable strategies focusing on the ideas, innovations and connections that will drive transformative change at the AHA Leadership Summit.
“This was never about technology,” said Muhammad Siddiqui.
That sounds like a strange way to describe the project that made Reid Health one of the finalists for the 2026 AHA Rural Hospital Excellence in Innovation Award.
The American Hospital Association (AHA) writes to alert you to the latest development in connection with the growing number of drug company policies requiring covered entities to submit onerous amounts of claims data in exchange for their statutorily owed 340B discounts.